BioSyntech, Inc.
BSYI · OTC
3/31/2009 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -85.1% | 12.5% | 295.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.8% | 62.8% | 63.1% | 65.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26,043.2% | -3,197.6% | -3,240.5% | -9,439.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -31,739.1% | -3,383.8% | -3,332.4% | -11,145.5% |
| EPS Diluted | -0.13 | -0.1 | -0.09 | -0.17 |
| % Growth | -30% | -11.1% | 47.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |